(InSilico Medicine, Inc.) Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest results in modern and next-generation AI for Drug Discovery and productive longevity at AI Innovation in Pharma – Asia Pharma R&D Leaders Summit 2019 in Shanghai, April 16-17.

Original source: https://www.eurekalert.org/pub_releases/2019-03/imi-itp030619.php